Novel Therapeutic Approaches for Cancer Treatment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 January 2025 | Viewed by 119
Special Issue Editor
Interests: antineoplastic pharmacology; drug delivery; drug resistance; drug discovery; photodynamic therapy; tumor hypoxia
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer affects a significant proportion of the global population and, according to the World Health Organization (WHO), is the second cause of death worldwide. Genetic and epigenetic alterations are among the most critical factors in the onset of carcinomas. Nevertheless, several lifestyle factors, such as physical inactivity, alcohol consumption, smoking, poor nutrition and exposure to ultraviolet radiation or X-rays, can contribute to the transition of healthy cells into malignant cells.
Conventional treatment approaches, such as surgery, chemotherapy and radiotherapy, are still in use, while significant advances are being made in various fields, including stem cell therapy, targeted therapy, ablation therapy, nanoparticles, natural antioxidants, photodynamic therapy, sonodynamic therapy, immunotherapy and ferroptosis-based therapy. However, to overcome the drawbacks associated with the strategies currently in use in the clinic, novel therapeutic options are needed. This has prompted the research of additional drugs and drug delivery strategies to offer more effective therapeutic alternatives.
This Special Issue aims at collecting original research articles and comprehensive reviews on the most recent advances concerning cancer treatment, such as, but not limited to, novel small anticancer molecules, epigenetic drugs, nanotechnology-based combination therapies, targeted therapies including external stimuli-activated approaches, drug repurposing and immunotherapeutic.
Prof. Dr. Marzia Bruna Gariboldi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- small molecules
- epigenetic drugs
- drug delivery system
- targeted therapy
- personalized medicine
- photodynamic therapy
- photothermal therapy
- sonodynamic therapy
- drug repurposing
- combination therapy
